A Clinical Trial to study the effect of the Drug Akkini chooranam (Internal) and Veera mezhugu (external) in patients having pain in sole of the foot

An open clinical trial of Siddha drugs â??Akkini chooranamâ?? (internal) and â??Veera mezhuguâ?? (external) in the treatment of â??Kuthikaal vaathamâ?? (Plantar fasciitis)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/06/008931

Enrollment

Registered

2017-06-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Kuthikaal vaatham (Plantar fasciitis)

Interventions

Intervention1: Akkini chooranam (Internal) and Veera mezhugu (External): 1.5 gm of Akkini chooranam will be administered orally twice a day for a period of 48 days.Veera mezhugu (Q.S) will be issued t

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pain and tenderness in the sole of the foot while on walking and standing

Exclusion criteria

Exclusion criteria: 1.H/o Cardiac diseases 2.H/o Diabetes mellitus 3.H/o Rheumatoid arthritis 4.H/o Chronic kidney disease 5.Pregnancy and lactation 6.Septic arthritis 7.Gonococcal arthritis 8.Psoriatic arthritis 9.Patient with any other serious systemic illness.

Design outcomes

Primary

Measure	Time frame
Primary outcome of the study is pain relieving and it will be assessed by Universal Pain assessment scale (before and after treatment). Restricted movement assessment scale (before and after treatment) and Questionnaire. Timepoint: 48 days	—

Secondary

Measure	Time frame
Reduction in Associated factors of Kuthikaal vaatham by Age, Sex, BMI and occupation.Timepoint: NIL	—

Countries

India

Contacts

Public ContactDr M Padmavathi

National Institute of Siddha

njmuthu@hotmail.com9444206843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026